Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.55B | $10.3B | $11.3B | $11.6B | $14.0B | $13.1B | $11.9B | $12.2B | $13.0B | $14.0B |
| Revenue growth | — | 7.9% | 9.9% | 2.0% | 21.0% | -6.0% | -9.7% | 2.5% | 7.0% | 7.2% |
| Gross profit | $2.85B | $3.09B | $3.18B | $3.25B | $4.95B | $4.99B | $3.71B | $3.36B | $3.62B | $4.01B |
| Gross margin | 29.9% | 30.0% | 28.0% | 28.1% | 35.4% | 38.0% | 31.3% | 27.7% | 27.9% | 28.8% |
| Operating income | $1.27B | $1.31B | $1.33B | $1.33B | $2.45B | $3.05B | $1.44B | $726M | $1.09B | $1.38B |
| Operating margin | 13.3% | 12.7% | 11.7% | 11.5% | 17.5% | 23.2% | 12.1% | 6.0% | 8.4% | 9.9% |
| Net income | $712M | $1.23B | $884M | $824M | $1.56B | $2.38B | $1.28B | $418M | $746M | $877M |
| Net margin | 7.5% | 11.9% | 7.8% | 7.1% | 11.1% | 18.1% | 10.8% | 3.4% | 5.7% | 6.3% |
| EPS (diluted) | $6.82 | $11.81 | $8.61 | $8.35 | $15.88 | $24.39 | $13.97 | $4.77 | $8.84 | $10.46 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.20B | $1.50B | $1.31B | $1.44B | $2.14B | $3.11B | $1.96B | $1.33B | $1.59B | $1.64B |
| Capital expenditures | $279M | $313M | $380M | $400M | $382M | $422M | $429M | $454M | $490M | $435M |
| Free cash flow | $918M | $1.19B | $926M | $1.04B | $1.75B | $2.69B | $1.53B | $874M | $1.10B | $1.21B |
| Share buybacks | $43.9M | $338M | $700M | $450M | $100M | $1.67B | $1.10B | $1.00B | $250M | $450M |
| Dividends paid | — | — | — | — | — | — | $195M | $254M | $243M | $241M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $434M | $317M | $427M | $338M | $1.32B | $1.47B | $321M | $537M | $1.52B | $532M |
| Total assets | $14.2B | $16.7B | $16.2B | $18.0B | $20.1B | $20.4B | $20.2B | $16.7B | $18.4B | $18.4B |
| Total liabilities | $8.73B | $9.85B | $9.19B | $10.5B | $10.6B | $10.1B | $10.0B | $8.83B | $10.3B | $9.76B |
| Long-term debt | $5.30B | $6.34B | $5.99B | $5.79B | $5.42B | $5.42B | $5.04B | $4.05B | $5.33B | $5.08B |
| Shareholders' equity | $5.52B | $6.80B | $7.05B | $7.64B | $9.44B | $10.3B | $10.1B | $7.88B | $8.05B | $8.62B |
| Retained earnings | $4.97B | $6.20B | $7.16B | $7.98B | $9.48B | $10.5B | $10.6B | $7.89B | $8.30B | $8.64B |
| Shares (wtd avg diluted) | 104M | 104M | 103M | 98.6M | 98.0M | 97.5M | 91.6M | 87.6M | 84.4M | 83.8M |
Every figure is extracted from LABCORP HOLDINGS INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.